1,469
Views
90
CrossRef citations to date
0
Altmetric
Review

Proton pump inhibitors: use and misuse in the clinical setting

, , , ORCID Icon, , , , & show all
Pages 1123-1134 | Received 03 Jul 2018, Accepted 01 Oct 2018, Published online: 10 Oct 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (15)

Amir Mari, Elisa Marabotto, Mentore Ribolsi, Fabiana Zingone, Brigida Barberio, Vincenzo Savarino & Edoardo Vincenzo Savarino. (2023) Encouraging appropriate use of proton pump inhibitors: existing initiatives and proposals for the future. Expert Review of Clinical Pharmacology 0:0, pages 1-11.
Read now
Vincenzo Savarino, Elisa Marabotto, Patrizia Zentilin, Nicola De Bortoli, Pierfrancesco Visaggi, Manuele Furnari, Giorgia Bodini, Edoardo Giannini & Edoardo Savarino. (2023) How safe are heartburn medications and who should use them?. Expert Opinion on Drug Safety 22:8, pages 643-652.
Read now
Jianan Bao, Ling Zhou, Mengying Xu & Jingjing Ma. (2023) The impact of pharmacist intervention on the intravenous-to-oral switch therapy of proton pump inhibitors in cardiovascular surgery. Expert Opinion on Drug Safety 22:7, pages 611-619.
Read now
Iga Pawłowska, Karolina Kuźbicka, Natalia Krzyżaniak & Ivan Kocić. (2022) Interactions between selected over-the-counter drugs and food: clinical relevance and prevention. International Journal of Food Sciences and Nutrition 73:8, pages 1005-1018.
Read now
Rami B. Tarabay, Mona H. Osman, Riwa S. Aridi, Sani A. Hlais, Ranin Y. Beshara & Najla A. Lakkis. (2022) The effect of a patient informative leaflet on chronic use of proton pump inhibitors in a primary care center: a randomized control trial. Hospital Practice 50:4, pages 318-325.
Read now
Vincenzo Savarino, Luca Antonioli, Matteo Fornai, Elisa Marabotto, Maria Giulia Demarzo, Fabiana Zingone, Matteo Ghisa, Brigida Barberio, Patrizia Zentilin, Mentore Ribolsi & Edoardo Savarino. (2022) An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders. Expert Review of Gastroenterology & Hepatology 16:5, pages 401-410.
Read now
Kaifeng Chen, Ping Luo, Guoping Yang, Shaihong Zhu, Chenhui Deng, Junjie Ding, Yaqi Lin, Liyong Zhu & Qi Pei. (2022) Population pharmacokinetics of omeprazole in obese and normal-weight adults. Expert Review of Clinical Pharmacology 15:4, pages 461-471.
Read now
Taraneh Mousavi, Shekoufeh Nikfar & Mohammad Abdollahi. (2022) The pharmacotherapeutic management of duodenal and gastric ulcers. Expert Opinion on Pharmacotherapy 23:1, pages 63-89.
Read now
Vincenzo Savarino, Elisa Marabotto, Patrizia Zentilin, Maria Giulia Demarzo, Nicola de Bortoli & Edoardo Savarino. (2021) Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art. Drug Design, Development and Therapy 15, pages 1609-1621.
Read now
Jiquan Shen, Bo Wang, Shuanghu Wang, Feifei Chen, Deru Meng, Hui Jiang, Yunfang Zhou, Peiwu Geng, Quan Zhou & Bin Liu. (2020) Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats. Drug Design, Development and Therapy 14, pages 2199-2206.
Read now
Elisa Marabotto, Sebastiano Ziola, Vincenzo Savarino, Edoardo Giovanni Giannini, Manuele Furnari, Giorgia Bodini, Fabiana Zingone, Matteo Ghisa, Brigida Barberio, Patrizia Zentilin & Edoardo Savarino. (2020) Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data. Clinical and Experimental Gastroenterology 13, pages 99-104.
Read now
Steven G Chrysant & George S Chrysant. (2020) Adverse cardiovascular and blood pressure effects of drug-induced hypomagnesemia. Expert Opinion on Drug Safety 19:1, pages 59-67.
Read now
Vincenzo Savarino, Elisa Marabotto, Patrizia Zentilin & Edoardo Savarino. (2019) The prevention of NSAID-induced gastric ulcers is a firmly established PPI indication. Expert Review of Clinical Pharmacology 12:11, pages 1011-1012.
Read now
Steven G. Chrysant. (2019) Proton pump inhibitor-induced hypomagnesemia complicated with serious cardiac arrhythmias. Expert Review of Cardiovascular Therapy 17:5, pages 345-351.
Read now

Articles from other publishers (75)

Aslınur ALBAYRAK & İrem YILDIZ. (2023) KNOWLEDGE, ATTITUDES AND PRACTICES OF COMMUNITY PHARMACISTS ABOUT PROTON PUMP INHIBITORSSERBEST ECZACILARIN PROTON POMPASI İNHİBİTÖRLERİ HAKKINDAKİ BİLGİ, TUTUM VE UYGULAMALARI. Ankara Universitesi Eczacilik Fakultesi Dergisi 48:1, pages 11-11.
Crossref
Pauline Gendre, Severine Mayol, Julie Mocquard & Jean‐François Huon. (2023) Physicians' views on pharmacists' involvement in hospital deprescribing: A qualitative study on proton pump inhibitors. Basic & Clinical Pharmacology & Toxicology 133:6, pages 718-728.
Crossref
Wen Liu, Jia Wang, Miao Wang, Miaomiao Wang & Ming Liu. (2023) Association of proton pump inhibitor use with risk of kidney stones: an analysis of cross-sectional data from the US National Health and Nutrition Examination Survey (2007–2018). BMJ Open 13:10, pages e075136.
Crossref
Jianxin Wang, Chaoyi Li, Linliu Du, Shuocheng Qiu, Xiufang Zhu, Chengye Yan, Jiawei Shang, Qiao Wang & Huijun Xu. (2023) Experimental validation for mechanisms of Qizhiweitong particles against Chronic Non-atrophic gastritis based on metabolomics and network pharmacology. Journal of Pharmaceutical and Biomedical Analysis 234, pages 115549.
Crossref
Yong Kang Lee, Hyun Sun Lim, Youn I Choi, Eun Ju Choe, Seonji Kim, Seng Chan You, Kyung Joo Lee, Yerim Kim, Da Hee Park, Woon Geon Shin & Seung In Seo. (2023) Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction. Pharmaceuticals 16:9, pages 1213.
Crossref
Armin Ghomeshi, Boris Yang & Thomas A. Masterson. (2023) The adverse effects of commonly used medications on male fertility: a comprehensive review. F&S Reviews.
Crossref
Ludovica Venezia, Matteo Rossano Buonocore, Ilenia Barbuscio, Francesco Bortoluzzi, Fabio Monica, Guido Manfredi, Andrea Anderloni & Elisa Stasi. (2023) Choosing Wisely in Gastroenterology: five new recommendations from the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO). European Journal of Gastroenterology & Hepatology 35:7, pages 728-733.
Crossref
Natalie M. Elder, Sean F. Heavey & Katren R. Tyler. (2023) Emergency Department Pain Management in the Older Adult. Clinics in Geriatric Medicine.
Crossref
Amber N. Edinoff, Natalie W. Wu, Katelyn Parker, Edwin Dudossat, Lauren Linquest, Chelsi J. Flanagan, Anam Dharani, Hirni Patel, Olga Willett, Elyse M. Cornett, Adam M. Kaye & Alan D. Kaye. (2023) Proton Pump Inhibitors, Kidney Damage, and Mortality: An Updated Narrative Review. Advances in Therapy 40:6, pages 2693-2709.
Crossref
Yue Zhang, Nasrollah Ghahramani, Hadie Razjouyan, Djibril M. Ba & Vernon M. Chinchilli. (2023) The association between proton pump inhibitor use and risk of post-hospitalization acute kidney injury: a multicenter prospective matched cohort study. BMC Nephrology 24:1.
Crossref
Giammarco Baiardi, Giulia Calvini, Serena Panarello, Chiara Fioravanti, Manuela Stella, Antonietta Martelli, Giancarlo Antonucci & Francesca Mattioli. (2023) Prescriptive Appropriateness: Inhospital Adherence to Proton Pump Inhibitors Deprescription Flow Chart. Pharmaceuticals 16:5, pages 635.
Crossref
Giulia Calvini, Giammarco Baiardi, Francesca Mattioli, Giulia Milano, Francesca Calautti, Alessia Zunino, Carla Elda Fraguglia, Fabio Caccavale, Francesca Lantieri & Giancarlo Antonucci. (2023) Deprescribing Strategies: A Prospective Study on Proton Pump Inhibitors. Journal of Clinical Medicine 12:8, pages 3029.
Crossref
Orly Sneh-Arbib, Shir Ben-Shitrit, Yaara Leibovici Weisman, Shiri Koshnir, Zohar Levi & Bronya Calivarysky. (2023) Using an algorithm to assess the rate and trend over time of inappropriate proton pump inhibitors prescription upon hospital discharge. Digestive and Liver Disease 55:4, pages 485-489.
Crossref
Fitriya Yusof, Siriprapha Sanguanhong, Suchada Soorapan & Juraporn Pongwecharak. (2023) Trends in prescribing volumes and costs of proton pump inhibitors in three outpatient specialties: a three-year retrospective study in a tertiary hospital in Thailand. International Journal of Pharmacy Practice 31:1, pages 80-85.
Crossref
Sumera Zaib, Hira Javed, Hanan A. Ogaly & Imtiaz Khan. (2023) Evaluating the Anti‐Gastric Ulcer Activity of Aegle marmelos : A Brief Review . ChemistrySelect 8:10.
Crossref
Manuela Casula, Ilaria Ardoino & Carlotta Franchi. (2023) Appropriateness of the Prescription and Use of Medicines: An Old Concept but More Relevant than Ever. International Journal of Environmental Research and Public Health 20:3, pages 2700.
Crossref
Jean Félix Piñerúa-Gonsálvez, Rosanna del Carmen Zambrano-Infantino, Julio César Albornoz-Sandoval & Pedro Waykin Tong-Morao. (2023) Assessment of gastric-acid suppressants prescribing at an internal medicine service of a tertiary hospital in Latin America: A retrospective record review study. Revista de Gastroenterología del Perú 42:4, pages 242-7.
Crossref
Sharon Ngwenya, Johanna Simin & Nele Brusselaers. (2023) Maintenance Proton Pump Inhibitor Use Associated with Increased All-Cause and Cause-Specific Mortality in Sweden. Digestive Diseases and Sciences.
Crossref
Weiguo Fan, Hualong Liu, Yang Shen & Kui Hong. (2023) The Association of Proton Pump Inhibitors and QT Interval Prolongation in Critically Ill Patients. Cardiovascular Drugs and Therapy.
Crossref
Naina Mohamed Pakkir Maideen. (2023) Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors. Chonnam Medical Journal 59:2, pages 115.
Crossref
Miguel Del-Pino & Emilio J. Sanz. (2023) Analysis of deprescription strategies of proton pump inhibitors in primary care: a narrative review. Primary Health Care Research & Development 24.
Crossref
Lieke Maria Koggel, Marten Alexander Lantinga, Frederike Leonie Büchner, Joost Paulus Hubertus Drenth, Jacqueline Sarah Frankema, Edwin Johannes Heeregrave, Mette Heringa, Mattijs Everard Numans & Peter Derk Siersema. (2022) Predictors for inappropriate proton pump inhibitor use: observational study in primary care. British Journal of General Practice 72:725, pages e899-e906.
Crossref
Lei Fang, Wansi Zhong, Xiaoxian Gong, Zhicai Chen, Yi Chen, Shenqiang Yan & Min Lou. (2022) Association of Proton Pump Inhibitor Prophylaxis on Clinical Outcome in Acute Ischemic Stroke in China: A Multicenter Retrospective Cohort Study. Journal of Clinical Medicine 11:23, pages 6881.
Crossref
Pedro Fong, Sut Tong Chan, Pui Nap Lei, Hao Ian Cheong, I Man Cheong & Weng Lam Hoe. (2022) Association of suicidal ideation and depression with the use of proton pump inhibitors in adults: a cross-sectional study. Scientific Reports 12:1.
Crossref
Nataša Stojaković, Ana Golić Jelić, Svjetlana Stoisavljević Šatara, Nataša Bednarčuk, Miloš P. Stojiljković & Ranko Škrbić. (2022) Characteristics and Patterns of Proton Pump Inhibitors Prescribing at the Primary Health Care. Medicina 58:11, pages 1622.
Crossref
S. Domiati & R. Poushuju. (2022) Clinical pharmacist evaluation of medication inappropriateness in a geriatric hospital. Annales Pharmaceutiques Françaises 80:6, pages 876-884.
Crossref
Kaifeng Chen, Ping Luo, Shaihong Zhu, Yaqi Lin, Nan Yang, Shuqi Huang, Qin Ding, Liyong Zhu & Qi Pei. (2022) Effect of Laparoscopic Sleeve Gastrectomy on the Pharmacokinetics of Oral Omeprazole Using a Population Approach. Pharmaceutics 14:10, pages 1986.
Crossref
Theodoros Voulgaris, Vasileios Lekakis, Afroditi Orfanidou, Jiannis Vlachogiannakos, Dimitrios Kamberoglou, George Papatheodoridis & George Karamanolis. (2022) The Lyon Consensus Criteria for GERD Diagnosis in a Greek Population: The Clinical Impact and Changes in GERD Diagnosis in a Real-World, Retrospective Study. Journal of Clinical Medicine 11:18, pages 5383.
Crossref
Stefano Ciardullo, Federico Rea, Laura Savaré, Gabriella Morabito, Gianluca Perseghin & Giovanni Corrao. (2022) Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results From a Large Population-Based Nested Case-Control Study. The Journal of Clinical Endocrinology & Metabolism 107:7, pages e2671-e2679.
Crossref
Mei Wang, Michael Paterson, Lehana Thabane, Deborah Siegal, Lawrence Mbuagbaw, Laura Targownik & Anne Holbrook. (2022) Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study. BMJ Open 12:6, pages e057991.
Crossref
Bernard Bégaud. (2022) Alzheimer disease: Leave no stone unturned. European Journal of Neurology 29:5, pages 1289-1290.
Crossref
E. Fuentes-Valenzuela, P. Díez Redondo, J. Tejedor-Tejada, R. Nájera-Muñoz, L. Sánchez-Delgado & C. Maroto-Martín. (2022) Tratamiento con inhibidores de la bomba de protones. ¿Realmente lo necesita el paciente?. Medicina de Familia. SEMERGEN 48:2, pages 82-87.
Crossref
Ansgar W. Lohse & Samuel Huber. 2022. Arzneiverordnungs-Report 2022. Arzneiverordnungs-Report 2022 303 328 .
Alberto Magni, Piergiuseppe Agostoni, Cesare Bonezzi, Giuseppe Massazza, Paolo Menè, Vincenzo Savarino & Diego Fornasari. (2021) Management of Osteoarthritis: Expert Opinion on NSAIDs. Pain and Therapy 10:2, pages 783-808.
Crossref
Xiuyu Sui, Jin Guan, Xiaoyu Li, Lei Gu, Feng Yan, Shuang Shi & Dongxiang Zhang. (2021) Preparation of a polydopamine/β‐cyclodextrin coated open tubular capillary electrochromatography column and application for enantioseparation of five proton pump inhibitors. Journal of Separation Science 44:17, pages 3295-3304.
Crossref
Karen Clarke, Nicole Adler, Dimpal Bhakta, Suchita Shah Sata, Sarguni Singh, Arjun Gupta, Amit Pahwa, Emily Pherson, Alexander Sun, Frank Volpicelli & Hyung J Cho. (2021) Reducing Overuse of Proton Pump Inhibitors for Stress Ulcer Prophylaxis and Nonvariceal Gastrointestinal Bleeding in the Hospital: A Narrative Review and Implementation Guide. Journal of Hospital Medicine 16:7.
Crossref
Claudia C. Orelio, Pauline Heus, Judith J Kroese-van Dieren, René Spijker, Barbara C. van Munster & Lotty Hooft. (2021) Reducing Inappropriate Proton Pump Inhibitors Use for Stress Ulcer Prophylaxis in Hospitalized Patients: Systematic Review of De-Implementation Studies. Journal of General Internal Medicine 36:7, pages 2065-2073.
Crossref
Xiaofeng Ni, Mao Lin, Jialian Li, Linan ZengWenrui Li, Liang HuangDeyuan LiLingli Zhang. (2021) Development of an evaluation indicator system for the rational use of proton pump inhibitors in pediatric intensive care units. Medicine 100:24, pages e26327.
Crossref
So Young Kim, Chang Ho Lee, Chanyang Min, Dae Myoung Yoo & Hyo Geun Choi. (2021) Association between Proton Pump Inhibitors and Hearing Impairment: A Nested Case-Control Study. Current Issues in Molecular Biology 43:1, pages 142-152.
Crossref
Elisa Marabotto, Edoardo Savarino, Nicola de Bortoli & Edoardo G. Giannini. (2021) Refractoriness to Treatment Suggests That Clinical Evaluation Should Go Beyond the Diagnosis of Reflux Disease. Clinical Gastroenterology and Hepatology 19:5, pages 1077-1078.
Crossref
Alba Rocco, Debora Compare, Costantino Sgamato, Pietro Coccoli, Paolo Chiodini & Gerardo Nardone. (2020) Impact of proton pump inhibitors on cytochrome P450 activity assessed by 13 C‐aminopyrine breath test in patients with cirrhosis . Alimentary Pharmacology & Therapeutics 53:5, pages 608-615.
Crossref
Tonia Gerber & Andreas Zeller. (2021) Evidenzbasierte Indikation für Protonenpumpeninhibitoren – Erfahrungsbericht aus einer hausärztlichen Gruppenpraxis. Praxis 110:4, pages 193-200.
Crossref
J. Hartlev, S.E. Nørholt, S. Schou & F. Isidor. (2021) Pain after mandibular ramus block harvesting and lateral ridge augmentation with and without involvement of platelet-rich fibrin: a randomized controlled trial. International Journal of Oral and Maxillofacial Surgery 50:3, pages 384-390.
Crossref
Nele Brusselaers, Omid Sadr-Azodi & Lars Engstrand. (2021) Proton pump inhibitors and the risk of pancreatic cancer. Journal of Gastroenterology 56:3, pages 295-296.
Crossref
Marilia Carabotti, Bruno Annibale & Edith Lahner. (2021) Common Pitfalls in the Management of Patients with Micronutrient Deficiency: Keep in Mind the Stomach. Nutrients 13:1, pages 208.
Crossref
László Herszényi. (2021) Reflux Symptoms – Functional and Structural Diseases: The Approach from the General Practitioner. Digestive Diseases 39:6, pages 585-589.
Crossref
E. Van Tendeloo, J. Gutermuth & M. Grosber. (2020) Positive patch testing with omeprazole in Stevens‐Johnson syndrome: a case report. Journal of the European Academy of Dermatology and Venereology 35:1.
Crossref
Ansgar W. Lohse & Samuel Huber. 2021. Arzneiverordnungs-Report 2021. Arzneiverordnungs-Report 2021 523 550 .
Haralampos M. Moutsopoulos & Evangelia Zampeli. 2021. Immunology and Rheumatology in Questions. Immunology and Rheumatology in Questions 205 243 .
Davide Cucchi, Alessandra Menon, Francesca Maria Feroldi, Linda Boerci & Pietro Simone Randelli. (2020) The presence of gastroesophageal reflux disease increases the risk of developing postoperative shoulder stiffness after arthroscopic rotator cuff repair. Journal of Shoulder and Elbow Surgery 29:12, pages 2505-2513.
Crossref
Radek Kroupa, Ivana Katinova, Tomas Pavlik, Lumir Kunovsky, Vladimir Prochazka, Petra Borilova Linhartova, Barbora Packova, Zdenek Kala & Jiri Dolina. (2020) Incidence trends of esophageal cancer in the Czech Republic by histological subtype and stage and prescription rate of acid suppressing drugs. Cancer Epidemiology 69, pages 101853.
Crossref
Erik Puchon, Maria Goboova, Ivan Vano, Tomas Fazekas, Zuzana Javorova-Rihova & Magdalena Kuzelova. (2020) Medication-related factors associated with proton pump inhibitor prescription beyond official guidelines in older adults. European Geriatric Medicine 11:6, pages 1051-1061.
Crossref
Tianyi Ma, Meng Wu, Shengnan Jia & Lanlan Yang. (2020) Proton pump inhibitors and the risk of colorectal cancer: a systematic review and meta-analysis of observational studies. International Journal of Colorectal Disease 35:12, pages 2157-2169.
Crossref
Yujuan Liu, Xian Zhu, Rongxin Li, Jun Zhang & Feng Zhang. (2020) Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study. BMJ Open 10:11, pages e040473.
Crossref
Rachel McCormack, Louise Olley, Barbara Glanemann & James W. Swann. (2020) Prospective observational study of the use of omeprazole and maropitant citrate in veterinary specialist care. Scientific Reports 10:1.
Crossref
Mária Matuz, Ria Benkő, Zsófia Engi, Krisztina Schváb, Péter Doró, Réka Viola, Mária Szabó & Gyöngyvér Soós. (2020) Use of Proton Pump Inhibitors in Hungary: Mixed-Method Study to Reveal Scale and Characteristics. Frontiers in Pharmacology 11.
Crossref
Edoardo Savarino, Marzio Frazzoni, Elisa Marabotto, Patrizia Zentilin, Paola Iovino, Mario Costantini, Salvatore Tolone, Edda Battaglia, Michele Cicala, Paolo Usai-Satta, Nicola de Bortoli, Roberto Penagini & Vincenzo Savarino. (2020) A SIGE-SINGEM-AIGO technical review on the clinical use of esophageal reflux monitoring. Digestive and Liver Disease 52:9, pages 966-980.
Crossref
Alexander C. Reisinger, Philipp Eller, Gernot Schilcher, Florian Eisner, Philipp Kreuzer, Gerald Hackl, Walter Spindelböck, Johannes Plank & Patrizia Kump. (2020) Manifestation of Zollinger-Ellison Syndrome With Hypovolemic Shock. The American Journal of Medicine 133:9, pages e460-e462.
Crossref
Christophe Karl Souaid, Rami George Maalouf, Souheil Hallit, Bassem Akiki & Elissar Dagher. (2020) Relevance of proton pump inhibitors prescriptions in a tertiary care hospital in Lebanon. Arab Journal of Gastroenterology 21:3, pages 194-198.
Crossref
Edoardo G. Giannini, Mattia Crespi, Afscin Djahandideh, Maria Giulia Demarzo, Alessandro Moscatelli, Giorgia Bodini, Manuele Furnari, Elisa Marabotto, Maria Corina Plaz Torres, Patrizia Zentilin & Vincenzo Savarino. (2020) Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation. Digestive and Liver Disease 52:8, pages 862-868.
Crossref
Vincenzo Savarino, Elisa Marabotto, Manuele Furnari, Fabiana Zingone, Patrizia Zentilin & Edoardo Savarino. (2020) Latest insights into the hot question of proton pump inhibitor safety – a narrative review. Digestive and Liver Disease 52:8, pages 842-852.
Crossref
D. Viñal, N. Rodriguez-Salas, P. Perez-Wert, O. Higuera, I. Ghanem & J. Feliu. (2019) Efficacy of capecitabine when used concomitantly with proton pump inhibitors in cancer patients: a systematic review. Clinical and Translational Oncology 22:8, pages 1288-1294.
Crossref
Jessica S. Tischendorf, Mary J. Knobloch, Jackson S. Musuuza & Nasia Safdar. (2020) Using a Systems Engineering Framework to Evaluate Proton Pump Inhibitor Prescribing in Critically Ill Patients. Journal for Healthcare Quality 42:4, pages e39-e49.
Crossref
Matteo Ghisa, Brigida Barberio, Vincenzo Savarino, Elisa Marabotto, Mentore Ribolsi, Giorgia Bodini, Fabiana Zingone, Marzio Frazzoni & Edoardo Savarino. (2020) The Lyon Consensus: Does It Differ From the Previous Ones?. Journal of Neurogastroenterology and Motility 26:3, pages 311-321.
Crossref
Edoardo Vincenzo Savarino, Paola Iovino, Antonella Santonicola, Matteo Ghisa, Giorgio Laserra, Brigida Barberio, Daria Maniero, Greta Lorenzon, Carolina Ciacci, Vincenzo Savarino & Fabiana Zingone. (2020) Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 Outbreak. Journal of Clinical Medicine 9:6, pages 2011.
Crossref
Mimi Xing, Rongzhan Fu, Yannan Liu, Pan Wang, Pei Ma, Chenhui Zhu & Daidi Fan. (2020) Human-like collagen promotes the healing of acetic acid-induced gastric ulcers in rats by regulating NOS and growth factors. Food & Function 11:5, pages 4123-4137.
Crossref
Su-Yeon Yu, Boram Lee, Treasure M. McGuire, Hye-Jae Lee & Samantha A. Hollingworth. (2019) Consumption of medicines used for gastric acid-related disorders in Australia and South Korea: a cross-country comparison. European Journal of Clinical Pharmacology 76:4, pages 547-555.
Crossref
Houpan Song, Meiyan Zeng, Xiaojuan Chen, Xinyi Chen, Jun Peng, Ye Lin, Rong Yu, Xiong Cai & Qinghua Peng. (2020) Antiulcerogenic Activity of Li-Zhong Decoction on Duodenal Ulcers Induced by Indomethacin in Rats: Involvement of TLR-2/MyD88 Signaling Pathway. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-14.
Crossref
Helmut Schiffl, Emad Al-Nemnem & SusanneM Lang. (2020) Proton-pump inhibitors and chronic kidney disease: Hidden consequences of an inappropriate drug use?. Saudi Journal of Kidney Diseases and Transplantation 31:2, pages 312.
Crossref
Ansgar W. Lohse & Samuel Huber. 2020. Arzneiverordnungs-Report 2020. Arzneiverordnungs-Report 2020 615 642 .
Diana Ching, Hussein El-Khatib & Anthony J. Pattin. (2019) Strategy to Improve Efficiency of Comprehensive Medication Reviews in a Community Pharmacy. Journal of Pharmacy Technology 35:5, pages 194-202.
Crossref
Yun-Jie Ma, Zong-Xun Cao, Yong Li & Shun-Yi Feng. (2019) Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis. World Journal of Gastroenterology 25:21, pages 2675-2682.
Crossref
Napapan Kangwan, Komsak Pintha, Suree Lekawanvijit & Maitree Suttajit. (2019) Rosmarinic Acid Enriched Fraction from Perilla frutescens Leaves Strongly Protects Indomethacin-Induced Gastric Ulcer in Rats . BioMed Research International 2019, pages 1-13.
Crossref
Ibrahim Masoodi. (2019) Prescription pattern of proton pump inhibitors among adults: A drug utilization study in the western region of Saudi Arabia.. International Journal of Medicine in Developing Countries, pages 699-704.
Crossref
Ansgar W. Lohse & Joachim Mössner. 2019. Arzneiverordnungs-Report 2019. Arzneiverordnungs-Report 2019 761 788 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.